The virus that causes severe acute respiratory syndrome coronavirus 2 is the source of the infectious sickness known as coronavirus disease 2019 (COVID-19) (SARS-CoV-2). In Wuhan, China, in December 2019, authorities discovered the first recorded case. The illness soon spread around the world, causing the COVID-19 pandemic. The signs and symptoms of COVID-19 might vary, but they frequently include fever, coughing, headaches, exhaustion, trouble breathing, loss of smell, and loss of taste. One to fourteen days after viral exposure, symptoms may appear. At least one-third of infected individuals don't have any symptoms at all. The virus that causes severe acute respiratory syndrome coronavirus 2 is the source of the infectious sickness known as coronavirus disease 2019 (COVID-19) (SARS-CoV-2 Most (81%) of individuals who experience symptoms that are obvious enough to qualify them as patients also experience mild to moderate symptoms, up to mild pneumonia, whereas 14% experience severe symptoms, such as dyspnea, hypoxia, or more than 50% lung involvement.
Speaker lineup for this track will be announced soon.
Browse all speakers →Background: Long COVID is associated with persistent multisystem symptoms following SARS-CoV-2 infection, yet objective tools to assess ongoing regulatory dysfunction remain limited. Previous…
Introduction : The COVID-19 pandemic has underscored the need for accurate predictive models to inform public health interventions. Traditional models like Autoregressive Integrated Moving Average…
Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post Coronavirus Disease 2019 (COVID-19) are chronic, multi-systemic illnesses that require multidisciplinary management…
We created a live, searchable and publicly available evidence and gap map (EGM) containing the existing evidence (published and unpublished) on determinants of the uptake and adherence to behaviours…
COVID-19 or Coronavirus is an infectious disease caused by the SARS-CoV2 virus, mainly affects the respiratory system which could be spread via contact or airborne. Symptoms include fever, cough…
The COVID-19 pandemic caused by SARS-CoV-2 that erupted in Wuhan China in 2019 has now been reduced greatly in many counties around the World (excepting China where a surge is ongoing) thanks to the…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Covid-19 work, reviewed by the scientific committee.
Meet public health researchers, educators, and policy leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Covid-19 research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Covid-19 track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Covid-19. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Covid-19 are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IPHC 2027 is a hybrid conference — attend the Covid-19 track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
